NASDAQ:CTKB
Cytek Biosciences, Inc.
- Stock
Last Close
6.18
17/05 20:00
Market Cap
1.15B
Beta: -
Volume Today
541.75K
Avg: 1.13M
PE Ratio
−73.77
PFCF: −132.08
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 20.73M - | 27.59M 33.14% | 40.16M 45.55% | 54.65M 36.07% | ||
average payables | 2.64M - | 2.99M 13.09% | 3.92M 31.13% | 3.86M 1.48% | ||
average receivables | 17.93M - | 23.93M 33.51% | 39.31M 64.27% | 52.75M 34.18% | ||
book value per share | -0.41 - | -0.51 24.22% | 5.30 1,142.81% | 3.16 40.30% | ||
capex per share | -0.01 - | -0.05 413.85% | -0.06 16.00% | -0.07 29.01% | ||
capex to depreciation | -3.15 - | -2.57 18.53% | -3.51 36.96% | -1.74 50.37% | ||
capex to operating cash flow | 0.07 - | -0.10 244.21% | -0.94 823.42% | 0.81 185.60% | ||
capex to revenue | -0.02 - | -0.02 0.87% | -0.03 104.68% | -0.06 76.38% | ||
cash per share | 0.30 - | 5.24 1,672.82% | 4.75 9.26% | 2.54 46.62% | ||
days of inventory on hand | 230.35 - | 204.27 11.32% | 240.59 17.78% | 278.71 15.84% | 267.88 3.89% | |
days payables outstanding | 29.27 - | 26.13 10.73% | 22.69 13.15% | 27.81 22.57% | 12.78 54.04% | |
days sales outstanding | 111.90 - | 71.18 36.39% | 84.90 19.27% | 108.73 28.07% | 106.90 1.69% | |
debt to assets | 0.10 - | 0.01 87.71% | 0.03 161.01% | 0.03 5.90% | 0.00 90.45% | |
debt to equity | -0.17 - | -0.17 0.01% | 0.04 121.70% | 0.04 13.39% | 0.00 90.17% | |
dividend yield | ||||||
earnings yield | -0.01 - | 0.03 472.82% | 0.00 89.24% | 0.00 46.82% | ||
enterprise value | 1.88B - | 429.56M 77.19% | 887.81M 106.68% | 1.09B 23.32% | -156.50M 114.29% | |
enterprise value over ebitda | 466.72 - | 27.96 94.01% | 115.46 313.04% | 285.64 147.38% | 8.92 96.88% | |
ev to operating cash flow | -136.99 - | 28.34 120.69% | 191.75 576.55% | -89.51 146.68% | ||
ev to sales | 32.53 - | 4.63 85.78% | 6.94 49.96% | 6.67 3.81% | -0.81 112.12% | |
free cash flow per share | -0.14 - | 0.43 398.80% | 0.00 99.20% | -0.16 4,839.87% | ||
free cash flow yield | -0.01 - | 0.02 398.80% | 0.00 99.08% | -0.02 7,676.36% | ||
graham net net | -0.58 - | -1.45 148.53% | 4.51 411.52% | 2.29 49.24% | ||
graham number | 1.23 - | 2.65 115.20% | 2.62 1.22% | 1.17 55.43% | ||
income quality | 0.82 - | 0.78 4.43% | 1.53 95.90% | -4.92 421.92% | ||
intangibles to total assets | 0.01 - | 0.00 67.54% | 0.03 841.40% | 0.03 13.18% | 0.03 21.41% | |
interest coverage | 3.73K - | 41.02 98.90% | 3.70 90.97% | -0.71 119.16% | -12.93 1,721.82% | |
interest debt per share | 0.07 - | 0.10 39.10% | 0.22 125.04% | 0.15 30.61% | ||
inventory turnover | 1.58 - | 1.79 12.77% | 1.52 15.10% | 1.31 13.68% | 1.36 4.04% | |
invested capital | -0.17 - | -0.17 0.01% | 0.04 121.70% | 0.04 13.39% | 0.00 90.17% | |
market cap | 1.91B - | 592.02M 69.06% | 1.25B 111.55% | 1.37B 9.66% | ||
net current asset value | -44.30M - | -27.39M 38.18% | 375.15M 1,469.92% | 360.09M 4.02% | 290.92M 19.21% | |
net debt to ebitda | -7.47 - | -10.57 41.63% | -47.42 348.52% | -72.66 53.22% | 8.92 112.28% | |
net income per share | -0.16 - | 0.62 472.82% | 0.06 90.64% | 0.02 66.73% | ||
operating cash flow per share | -0.13 - | 0.48 456.31% | 0.06 87.44% | -0.09 250.71% | ||
payables turnover | 12.47 - | 13.97 12.02% | 16.09 15.15% | 13.12 18.41% | 28.55 117.56% | |
receivables turnover | 3.26 - | 5.13 57.22% | 4.30 16.16% | 3.36 21.92% | 3.41 1.71% | |
research and ddevelopement to revenue | 0.15 - | 0.15 4.41% | 0.19 29.52% | 0.21 11.24% | 0.23 7.44% | |
return on tangible assets | -0.24 - | 0.09 136.63% | 0.01 88.89% | 0.01 48.17% | -0.02 564.21% | |
revenue per share | 0.57 - | 2.94 418.36% | 1.67 43.33% | 1.22 26.86% | ||
roe | 0.40 - | -1.21 400.13% | 0.01 100.90% | 0.01 44.26% | -0.03 574.86% | |
roic | -0.11 - | -1.39 1,142.32% | 0.01 100.82% | -0.01 169.18% | -0.05 547.63% | |
sales general and administrative to revenue | 0.12 - | 0.10 13.31% | 0.16 61.26% | 0.21 29.93% | ||
shareholders equity per share | -0.41 - | -0.51 24.22% | 5.30 1,142.81% | 3.16 40.30% | ||
stock based compensation to revenue | 0.00 - | 0.01 41.62% | 0.05 682.12% | 0.10 96.54% | ||
tangible asset value | -42.44M - | -16.78M 60.47% | 391.92M 2,435.90% | 411.07M 4.89% | 377.13M 8.26% | |
tangible book value per share | -0.42 - | -0.53 27.77% | 5.11 1,060.56% | 3.06 40.16% | ||
working capital | 46.73M - | 182.09M 289.69% | 399.89M 119.62% | 404.98M 1.27% | 336.08M 17.01% |
All numbers in USD (except ratios and percentages)